Change search
Link to record
Permanent link

Direct link
Gustafsson, Helena
Publications (10 of 10) Show all publications
Gustafsson, H., Runesson, J., Lundqvist, J., Lindegren, H., Axelsson, V. & Forsby, A. (2010). Neurofunctional endpoints assessed in human neuroblastoma SH-SY5Y cells for estimation of acute systemic toxicity. Toxicology and Applied Pharmacology, 245(2), 191-202
Open this publication in new window or tab >>Neurofunctional endpoints assessed in human neuroblastoma SH-SY5Y cells for estimation of acute systemic toxicity
Show others...
2010 (English)In: Toxicology and Applied Pharmacology, ISSN 0041-008X, E-ISSN 1096-0333, Vol. 245, no 2, p. 191-202Article in journal (Refereed) Published
Abstract [en]

The objective of the EU-funded integrated project ACuteTox is to develop a strategy in which general cytotoxicity, together with organ-specific toxicity and biokinetic features, are used for the estimation of human acute systemic toxicity. Our role in the project is to characterise the effect of reference chemicals with regard to neurotoxicity. We studied cell membrane potential (CMP), noradrenalin (NA) uptake, acetylcholine esterase (AChE) activity, acetylcholine receptor (AChR) signalling and voltage-operated calcium channel (VOCC) function in human neuroblastoma SH-SY5Y cells after exposure to 23 pharmaceuticals, pesticides or industrial chemicals. Neurotoxic alert chemicals were identified by comparing the obtained data with cytotoxicity data from the neutral red uptake assay in 3T3 mouse fibroblasts. Furthermore, neurotoxic concentrations were correlated with estimated human lethal blood concentrations (LC50). The CMP assay was the most sensitive assay, identifying eight chemicals as neurotoxic alerts and improving the LC50 correlation for nicotine, lindane, atropine and methadone. The NA uptake assay identified five neurotoxic alert chemicals and improved the LC50 correlation for atropine, diazepam, verapamil and methadone. The AChE, AChR and VOCC assays showed limited potential for detection of acute toxicity. The CMP assay was further evaluated by testing 36 additional reference chemicals. Five neurotoxic alert chemicals were generated and orphendrine and amitriptyline showed improved LC50 correlation. Due to the high sensitivity and the simplicity of the test protocol, the CMP assay constitutes a good candidate assay to be included in an in vitro test strategy for prediction of acute systemic toxicity.

Keywords
ACuteTox, Acute toxicity, Neurotoxicity In vitro, SH-SY5Y
National Category
Biological Sciences Chemical Sciences
Research subject
Neurochemistry with Molecular Neurobiology
Identifiers
urn:nbn:se:su:diva-50346 (URN)10.1016/j.taap.2010.02.018 (DOI)000278083100006 ()20211194 (PubMedID)
Funder
EU, European Research Council, LSHB-CT-2004-512051
Note

authorCount :6

Available from: 2010-12-22 Created: 2010-12-22 Last updated: 2022-02-24Bibliographically approved
Forsby, A., Bal-Price, A. K., Camins, A., Coecke, S., Fabre, N., Gustafsson, H., . . . Zurich, M. G. (2009). Neuronal in vitro models for the estimation of acute systemic toxicity.. Toxicology in vitro : an international journal published in association with BIBRA, 23(8), 1564-1569
Open this publication in new window or tab >>Neuronal in vitro models for the estimation of acute systemic toxicity.
Show others...
2009 (English)In: Toxicology in vitro : an international journal published in association with BIBRA, ISSN 1879-3177, Vol. 23, no 8, p. 1564-1569Article in journal (Refereed) Published
Abstract [en]

The objective of the EU funded integrated project "ACuteTox" is to develop a strategy in which general cytotoxicity, together with organ-specific endpoints and biokinetic features, are taken into consideration in the in vitro prediction of oral acute systemic toxicity. With regard to the nervous system, the effects of 23 reference chemicals were tested with approximately 50 endpoints, using a neuronal cell line, primary neuronal cell cultures, brain slices and aggregated brain cell cultures. Comparison of the in vitro neurotoxicity data with general cytotoxicity data generated in a non-neuronal cell line and with in vivo data such as acute human lethal blood concentration, revealed that GABA(A) receptor function, acetylcholine esterase activity, cell membrane potential, glucose uptake, total RNA expression and altered gene expression of NF-H, GFAP, MBP, HSP32 and caspase-3 were the best endpoints to use for further testing with 36 additional chemicals. The results of the second analysis showed that no single neuronal endpoint could give a perfect improvement in the in vitro-in vivo correlation, indicating that several specific endpoints need to be analysed and combined with biokinetic data to obtain the best correlation with in vivo acute toxicity.

Keywords
Animal Testing Alternatives, Calcium/metabolism, Cosmetics/toxicity, Eye Diseases/*chemically induced, Humans, Models; Biological, Neuroblastoma, Neurons; Afferent/*drug effects, Receptors; Drug/analysis/drug effects/physiology, Soaps/toxicity, Toxicity Tests, Tumor Cells; Cultured
Identifiers
urn:nbn:se:su:diva-32621 (URN)10.1016/j.tiv.2009.07.017 (DOI)000272276600021 ()19615435 (PubMedID)
Projects
EU 6th FWP ACuteTox
Available from: 2009-12-14 Created: 2009-12-14 Last updated: 2022-02-25Bibliographically approved
Gustafsson, H., Runesson, J., Lindegren, H., Axelsson, V. & Forsby, A. (2007). The use of the human neuroblastoma SH-SY5Y cell line for estimation of acute systemic toxicity in vitro..
Open this publication in new window or tab >>The use of the human neuroblastoma SH-SY5Y cell line for estimation of acute systemic toxicity in vitro.
Show others...
2007 (English)Conference paper, Published paper (Refereed)
Abstract [en]

Acute systemic toxicity, expressed as human lethal blood peak concentration or the dose inducing 50 % lethality in an animal population (LD50), can be estimated by general cytotoxicity tests using proliferating mammalian cell lines for 70-80 % of all chemicals. The cytotoxicity for the remaining chemicals over or under estimate the LD50 values/human lethal blood peak concentrations because of their very specific molecular targets or toxicokinetic features in vivo. The objective of the EU funded integrated project “ACuteTox” is to develop a strategy in which organ-specific endpoints and toxicokinetic features are taken into consideration in the in vitro prediction of acute systemic toxicity. The human neurotblastoma SH-SY5Y cell line was used as a model for studies on neurospecific targets, which are know to be crucial for survival. All endpoints were investigated after short exposure times (minutes to an hour) at concentrations of the test chemicals that did not affect the cell viability, measured as cell membrane leakage of lactate dehydrogenase. The effects of 23-26 compounds (drugs, pesticides and industrial chemicals) were studied on the cell membrane potential (CMP), voltage dependent Ca2+ channels (VDCC), muscarinic acetylcholine receptor (mAChR) function, acetylcholinesterase (AChE) activity and noradrenalin uptake. The results showed that the CMP was altered by atropine, amphetamine, mercury chloride, methadone, nicotine, pentachlorphenol, sodium lauryl sulphate (SLS) and verapamil, where as an effect on VDCC could be detected for amphetamine, atropine, colchicine, pentachlorphenol, SLS and verapamil. The mAChR function was measured as carbachol-induced Ca2+, i.e. activation of phospholipase C. Amphetamine, pentachlorphenol, SDS and verapamil attenuated the carbachol response by 50% at concentrations about 1 mM, but the specific mAChR antagonist atropine had the same effect at 3 nM. Nicotine, caffeine, pentachlorphenol, methadone, mercury chloride, SLS and the specific inhibitors physostigmine, dichlorvos and malathion attenuated the AChE activity at significantly non-cytotoxic concentrations in SH-SY5Y cells after 60 minutes of exposure. Parathion did not inhibit the AChE activity after 60 minutes exposure, but after 48 hr, indicating that oxidation of parathion to the active inhibitor paraoxon took place in the cell culture. This phenomenon was also observed for malathion, which displayed a lower EC50 value after the prolonged exposure time. The noradrenalin uptake was affected by atropine, caffeine, carbamazepine, amphetamine, diazepam, isopropanol, methadone, SLS and verapamil. A comparison of the active concentrations with the basal cytotoxicity measured as neutral red uptake in mouse fibroblast 3T3 cells indicated that the AChE assay is useful for detection of AChE inhibitors and possibly also AChR ligands. The VDCC endpoint was useful as an alert only for verapamil and the mAChR function was only specifically affected by atropine. The noradrenalin uptake indicated a clear alert for amphetamine and methadone, which was expected, but not for the other test compounds. These results indicate that the usefulness of these endpoints in a general test battery for estimation of acute systemic toxicity is limited, except for AChE activity measurements. However, the results clearly showed that the compounds with known mechanisms (e.g. atropine, verapamil, amphetamine and methodone ) displayed expected effects on their specific endpoints.

Keywords
Acute toxicity, in vitro, SH-SY5Y, human cell line, alternative methods
National Category
Pharmacology and Toxicology
Identifiers
urn:nbn:se:su:diva-20504 (URN)
Note
Presenterades muntligen vid 25th SSCT workshop, Sept 19-21, 2007, Salzau, GermanyAvailable from: 2007-11-26 Created: 2007-11-26 Last updated: 2022-02-25Bibliographically approved
Axelsson, V., Holback, S., Sjögren, M., Gustafsson, H. & Forsby, A. (2006). Gliotoxin induces caspase-dependent neurite degeneration and calpain-mediated general cytotoxicity in differentiated human neuroblastoma SH-SY5Y cells.. Biochem Biophys Res Commun, 345(3), 1068-74
Open this publication in new window or tab >>Gliotoxin induces caspase-dependent neurite degeneration and calpain-mediated general cytotoxicity in differentiated human neuroblastoma SH-SY5Y cells.
Show others...
2006 (English)In: Biochem Biophys Res Commun, ISSN 0006-291X, Vol. 345, no 3, p. 1068-74Article in journal (Refereed) Published
Abstract [en]

In this study, a significant increase by 50% in intracellular free calcium concentration ([Ca(2+)](i)) was observed in differentiated human neuroblastoma (SH-SY5Y) cells after exposure to 0.25microM of the fungal metabolite gliotoxin for 72h. Further, the involvement of caspases and calpains was demonstrated to underlie the gliotoxin-induced cytotoxic and neurite degenerative effects. The caspase inhibitor Z-VAD-fmk almost completely reduced the neurite degeneration from 40% degeneration of neurites to 5% as compared to control. Inhibition of calpains with calpeptin significantly attenuated gliotoxin-induced cytotoxicity, determined as reduction in total cellular protein content, from 43% to 14% as compared to control cells. Western blot analyses of alphaII-spectrin breakdown fragments confirmed activity of the proteases, and that alphaII-spectrin was cleaved by caspases in gliotoxin-exposed cells. These results show that calpains and caspases have a role in the toxicity of gliotoxin in differentiated SH-SY5Y cells and that the process may be Ca(2+)-mediated.

Keywords
Calcium/metabolism, Calpain/*metabolism, Caspases/*metabolism, Cell Differentiation, Cell Line;/pharmacology, Gliotoxin/*pharmacology, Humans, Immunosuppressive Agents/*pharmacology, Neurites/*metabolism, Neuroblastoma/*metabolism, Spectrin/metabolism
National Category
Pharmacology and Toxicology
Identifiers
urn:nbn:se:su:diva-20495 (URN)16712786 (PubMedID)
Available from: 2007-11-26 Created: 2007-11-26 Last updated: 2022-02-25Bibliographically approved
Gustafsson, H., Söderdahl, T., Jönsson, G., Bratteng, J.-O. & Forsby, A. (2004). Insulin-like growth factor type 1 prevents hyperglycemia-induced uncoupling protein 3 down-regulation and oxidative stress. Journal of Neuroscience Research, 77(2), 285-291
Open this publication in new window or tab >>Insulin-like growth factor type 1 prevents hyperglycemia-induced uncoupling protein 3 down-regulation and oxidative stress
Show others...
2004 (English)In: Journal of Neuroscience Research, ISSN 0360-4012, E-ISSN 1097-4547, Vol. 77, no 2, p. 285-291Article in journal (Refereed) Published
Abstract [en]

Uncoupling proteins (UCPs) have been reported to decrease the mitochondrial production of reactive oxygen species (ROS) by lowering the mitochondrial inner membrane potential (MMP). We have previously shown that UCP3 expression is positively regulated by insulin-like growth factor-1 (IGF-1). The aim of this study was to investigate the role of UCPs in IGF-1-mediated protection from hyperglycemia-induced oxidative stress and neurodegeneration. Human neuroblastoma SH-SY5Y cells were differentiated with retinoic acid for 6 days, after which exposure to 8, 30, or 60 mM glucose with or without 10 nM IGF-1 was started. After 48-72 hr, the number of neurites per cell, UCP3 protein expression, MMP, and intracellular levels of ROS and total glutathione were examined. These studies showed that glucose concentration-dependently reduced the number of neurites per cell, with a 50% reduction at 60 mM. In parallel, the UCP3 protein expression was down-regulated, and the MMP was raised 3.5-fold, compared with those in cells incubated with 8 mM glucose. Also, the ROS levels were increased, showing a twofold maximum at 60 mM glucose. This was accompanied by a twofold elevation of total glutathione levels, confirming an altered cellular redox state. IGF-1 treatment prevented the glucose-induced neurite degeneration and UCP3 down-regulation. Furthermore, the MMP and the intracellular levels of ROS and glutathione were normalized to those of control cells. These data indicate that IGF-1 may protect from hyperglycemia-induced oxidative stress and neuronal injuries by regulating MMP, possibly by the involvement of UCP3.

Keywords
diabetes, neuropathy, uncoupling protein, ROS, SH-SY5Y
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:su:diva-20496 (URN)10.1002/jnr.20142 (DOI)15211595 (PubMedID)
Available from: 2007-11-26 Created: 2007-11-26 Last updated: 2022-02-25Bibliographically approved
Gustafsson, H., Tamm, C. & Forsby, A. (2004). Signalling pathways for insulin-like growth factor type 1-mediated expression of uncoupling protein 3.. J Neurochem, 88(2), 462-8
Open this publication in new window or tab >>Signalling pathways for insulin-like growth factor type 1-mediated expression of uncoupling protein 3.
2004 (English)In: J Neurochem, ISSN 0022-3042, Vol. 88, no 2, p. 462-8Article in journal (Refereed) Published
Abstract [en]

Uncoupling protein 3 (UCP3) is a mitochondrial protein with antioxidant properties and its regulation by factors promoting cell-survival may be important for protection of, for instance, neurons in states of oxidative stress. In the present study, we investigated regulatory pathways for UCP3 expression mediated by the neuroprotective hormone insulin-like growth factor type 1 (IGF-1) in human neuroblastoma SH-SY5Y cells. Northern blot analysis and RT-PCR showed that treatment with 10 nm IGF-1 increased the UCP3 mRNA levels 2.5-fold after 5 h. Co-incubation with the phosphatidylinositol 3 (PI3)-kinase inhibitor LY294002 prohibited IGF-1-mediated induction of both UCP3 mRNA and protein in a concentration-dependent manner, with a complete blockage at 1 microm, as shown by RT-PCR and western blot analyses. The mitogen-activated protein (MAP) kinase kinase 1 (MKK1 or MEK) inhibitor PD98059 also decreased the UCP3 mRNA expression at 10 microm, however, this concentration only partly inhibited the protein expression. We conclude that IGF-1 enhanced UCP3 expression at transcriptional level, primarily through the PI3-kinase-dependent pathway and partly through the MAP kinase pathway.

Keywords
1-Phosphatidylinositol 3-Kinase/physiology, Carrier Proteins/*biosynthesis/genetics, Cell Line; Tumor, Gene Expression Regulation/*physiology, Humans, Insulin-Like Growth Factor I/*physiology, Ion Channels, MAP Kinase Signaling System/physiology, Mitochondrial Proteins, Signal Transduction/*physiology
National Category
Cell and Molecular Biology
Identifiers
urn:nbn:se:su:diva-20500 (URN)14690534 (PubMedID)
Available from: 2007-11-26 Created: 2007-11-26 Last updated: 2022-02-25Bibliographically approved
Gustafsson, H., Tamm, C. & Forsby, A. (2004). Signalling pathways for insulin-like growth factor type 1-mediated expression of uncoupling protein 3. Journal of Neurochemistry, 88(2), 462-468
Open this publication in new window or tab >>Signalling pathways for insulin-like growth factor type 1-mediated expression of uncoupling protein 3
2004 (English)In: Journal of Neurochemistry, ISSN 0022-3042, E-ISSN 1471-4159, Vol. 88, no 2, p. 462-468Article in journal (Refereed) Published
Abstract [en]

Uncoupling protein 3 (UCP3) is a mitochondrial protein with antioxidant properties and its regulation by factors promoting cell-survival may be important for protection of, for instance, neurons in states of oxidative stress. In the present study, we investigated regulatory pathways for UCP3 expression mediated by the neuroprotective hormone insulin-like growth factor type 1 (IGF-1) in human neuroblastoma SH-SY5Y cells. Northern blot analysis and RT-PCR showed that treatment with 10 nm IGF-1 increased the UCP3 mRNA levels 2.5-fold after 5 h. Co-incubation with the phosphatidylinositol 3 (PI3)-kinase inhibitor LY294002 prohibited IGF-1-mediated induction of both UCP3 mRNA and protein in a concentration-dependent manner, with a complete blockage at 1 μm, as shown by RT-PCR and western blot analyses. The mitogen-activated protein (MAP) kinase kinase 1 (MKK1 or MEK) inhibitor PD98059 also decreased the UCP3 mRNA expression at 10 μm, however, this concentration only partly inhibited the protein expression. We conclude that IGF-1 enhanced UCP3 expression at transcriptional level, primarily through the PI3-kinase-dependent pathway and partly through the MAP kinase pathway.

Keywords
IGF-1, MAP kinase, oxidative stress, PI3-kinase, SH-SY5Y, uncoupling protein
National Category
Neurosciences
Identifiers
urn:nbn:se:su:diva-22833 (URN)10.1046/j.1471-4159.2003.02162.x (DOI)
Note
Part of urn:nbn:se:su:diva-121Available from: 2004-04-28 Created: 2004-04-28 Last updated: 2022-02-25Bibliographically approved
Clemedson, C., Nordin-Andersson, M., Bjerregaard, H. F., Clausen, J., Forsby, A., Gustafsson, H., . . . Scheers, E. (2002). Development of an in vitro test battery for the estimation of acute human systemic toxicity: An outline of the EDIT project. Evaluation-guided Development of New In Vitro Test Batteries. ATLA (Alternatives to Laboratory Animals), 30(3), 313-321
Open this publication in new window or tab >>Development of an in vitro test battery for the estimation of acute human systemic toxicity: An outline of the EDIT project. Evaluation-guided Development of New In Vitro Test Batteries
Show others...
2002 (English)In: ATLA (Alternatives to Laboratory Animals), ISSN 0261-1929, Vol. 30, no 3, p. 313-321Article in journal (Refereed) Published
Abstract [en]

The aim of the Evaluation-guided Development of new In Vitro Test Batteries (EDIT) multicentre programme is to establish and validate in vitro tests relevant to toxicokinetics and for organ-specific toxicity, to be incorporated into optimal test batteries for the estimation of human acute systemic toxicity. The scientific basis of EDIT is the good prediction of human acute toxicity obtained with three human cell line tests (R(2) = 0.77), in the Multicentre Evaluation of In Vitro Cytotoxicity (MEIC) programme. However, the results from the MEIC study indicated that at least two other types of in vitro test ought to be added to the existing test battery to improve the prediction of human acute systemic toxicity - to determine key kinetic events (such as biotransformation and passage through biological barriers), and to predict crucial organ-specific mechanisms not covered by the tests in the MEIC battery. The EDIT programme will be a case-by-case project, but the establishment and validation of new tests will be carried through by a common, step-wise procedure. The Scientific Committee of the EDIT programme defines the need for a specific set of toxicity or toxicokinetic data. Laboratories are then invited to perform the defined tests in order to provide the "missing" data for the EDIT reference chemicals. The results obtained will be evaluated against the MEMO (the MEIC Monograph programme) database, i.e. against human acute systemic lethal and toxicity data. The aim of the round-table discussions at the 19th Scandinavian Society for Cell Toxicology (SSCT) workshop, held in Ringsted, Denmark on 6-9 September 2001, was to identify which tests are the most important for inclusion in the MEIC battery, i.e. which types of tests the EDIT programme should focus on. It was proposed that it is important to include in vitro methods for various kinetic events, such as biotransformation, absorption in the gut, passage across the blood-brain barrier, distribution volumes, protein binding, and renal clearance/accumulation. Models for target organ toxicity were also discussed. Because several of the outlier chemicals (paracetamol, digoxin, malathion, nicotine, paraquat, atropine and potassium cyanide) in the MEIC in vivo-in vitro evaluation have a neurotoxic potential, it was proposed that the development within the EDIT target organ programme should initially be focused on the nervous system.

Keywords
Biotransformation, Blood-Brain Barrier, DNA Damage, Humans, Intestinal Absorption, Kidney/metabolism, Protein Binding, Quantitative Structure-Activity Relationship, Toxicology/*methods
National Category
Pharmacology and Toxicology
Identifiers
urn:nbn:se:su:diva-20502 (URN)12106010 (PubMedID)
Available from: 2007-11-26 Created: 2007-11-26 Last updated: 2022-02-25Bibliographically approved
Gustafsson, H., Adamson, L., Hedander, J., Walum, E. & Forsby, A. (2001). Insulin-like growth factor type 1 upregulates uncoupling protein 3.. Biochem Biophys Res Commun, 287(5), 1105-11
Open this publication in new window or tab >>Insulin-like growth factor type 1 upregulates uncoupling protein 3.
Show others...
2001 (English)In: Biochem Biophys Res Commun, ISSN 0006-291X, Vol. 287, no 5, p. 1105-11Article in journal (Refereed) Published
Abstract [en]

In this study the expression of uncoupling protein 3 (UCP3) and its regulation by insulin-like growth factor 1 (IGF-I) and insulin in human neuroblastoma SH-SY5Y cells were characterized. Reverse transcriptase-PCR, Western blot, and immunofluorescence analysis showed that SH-SY5Y cells express UCP3 natively. IGF-I induced a time- and concentration-dependent induction of UCP3 protein reaching a twofold expression after 72 h with 10 nM IGF-I. Extremely high insulin concentrations (860 nM) and 10 nM trIGF-I, a truncated form of IGF-I with the same affinity for the IGF-I receptor as the full-length IGF-I, but with lower activity on the insulin receptor, also upregulated UCP3. We conclude that SH-SY5Y cells express UCP3 natively and that the expression is regulated by IGF-I via the IGF-I receptor. Copyright 2001 Academic Press.

Keywords
Carrier Proteins/biosynthesis/*genetics, Diabetes Mellitus; Type 2/metabolism, Diabetic Neuropathies/etiology, Humans, Insulin/pharmacology, Insulin-Like Growth Factor I/*pharmacology, Ion Channels, Mitochondria/metabolism, Mitochondrial Proteins, Nerve Tissue/drug effects/*metabolism, Neuroblastoma, Receptor; IGF Type 1/isolation & purification, Receptor; Insulin/isolation & purification, Tumor Cells; Cultured, Uncoupling Agents/metabolism, Up-Regulation
National Category
Cell Biology
Identifiers
urn:nbn:se:su:diva-20503 (URN)11587536 (PubMedID)
Available from: 2009-01-23 Created: 2009-01-23 Last updated: 2022-02-25Bibliographically approved
Gustafsson, H., Adamson, L., Hedander, J., Walum, E. & Forsby, A. (2001). Insulin-like growth factor type 1 up-regulates uncoupling protein 3. Biochemical and Biophysical Research Communications - BBRC, 287(5), 1105-1111
Open this publication in new window or tab >>Insulin-like growth factor type 1 up-regulates uncoupling protein 3
Show others...
2001 (English)In: Biochemical and Biophysical Research Communications - BBRC, ISSN 0006-291X, E-ISSN 1090-2104, Vol. 287, no 5, p. 1105-1111Article in journal (Refereed) Published
Abstract [en]

In this study the expression of uncoupling protein 3 (UCP3) and its regulation by insulin-like growth factor 1 (IGF-I) and insulin in human neuroblastoma SH-SY5Y cells were characterized. Reverse transcriptase-PCR, Western blot, and immunofluorescence analysis showed that SH-SY5Y cells express UCP3 natively. IGF-I induced a time- and concentration-dependent induction of UCP3 protein reaching a twofold expression after 72 h with 10 nM IGF-I. Extremely high insulin concentrations (860 nM) and 10 nM trIGF-I, a truncated form of IGF-I with the same affinity for the IGF-I receptor as the full-length IGF-I, but with lower activity on the insulin receptor, also upregulated UCP3. We conclude that SH-SY5Y cells express UCP3 natively and that the expression is regulated by IGF-I via the IGF-I receptor.

Keywords
uncoupling protein, IGF-I, SH-SY5Y, insulin, diabetes
National Category
Neurosciences
Identifiers
urn:nbn:se:su:diva-22832 (URN)10.1006/bbrc.2001.5702 (DOI)
Note
Part of urn:nbn:se:su:diva-121Available from: 2004-04-28 Created: 2004-04-28 Last updated: 2022-02-25Bibliographically approved
Organisations

Search in DiVA

Show all publications